Report from the 16th Conference on Retroviruses and Opportunistic Infections. Continued concern about abacavir and cardiovascular risk.
Henry
Keith
K
D002318:Cardiovascular Diseases / Q000139:chemically induced*; D015224:Dideoxynucleosides / Q000009:adverse effects*; D006801:Humans; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects*; D019562:Viral Load; D000099227:Abacavir
D015224:Dideoxynucleosides; D018894:Reverse Transcriptase Inhibitors; D000099227:Abacavir